CClinicalTrials.gg
Not yet recruitingNCT07622082Updated Jun 2, 2026

Out-of-hospital Cardiac Arrest Epidemiology and Outcomes in Western Lithuania 2022-2028

An observational study in Out-of-hospital Cardiac Arrest (OHCA), sponsored by Lithuanian University of Health Sciences. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Lithuanian University of Health Sciences · Observational

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
4,000
Ages
18 Years and older
Sex
All
01

Study summary

Out-of-hospital cardiac arrest rate is common problem, because of high mortality rate. It is not clear incidence rate, epidemiology and outcomes in Lithuania

Read the detailed description

This data reported according to UTSTEIN guidelines could be compared with other countries from the region although not much data is available, but it will be a baseline for future references about processes in patient management, demographics, incidence rate and OHCA outcomes.

02

Conditions studied

  • Out-of-hospital Cardiac Arrest (OHCA)
03

In context

Out-of-Hospital Cardiac Arrest

323 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 89 are open to participants now.

This study's planned enrollment of 4,000 is above the median of 300 across 131 observational studies indexed under Out-of-Hospital Cardiac Arrest.

Browse Out-of-Hospital Cardiac Arrest studies →

Lead sponsor

Lithuanian University of Health Sciences is the lead sponsor of 102 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

only adults

Inclusion criteria

  • people experiencing out-of-hospital cardiac arrest

Exclusion criteria

Exclusion Criteria:

  • all others
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
4,000 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Subgroup 2021-2025

    Subgroup before change of dispatcher protocol

  • Subgroup 2026-2028

    Subgroup after change of dispatcher protocol

    Behavioral: Protocol based

Interventions

  • BehavioralProtocol based

    change of EMS dispatcher protocol

06

What researchers measure

Primary outcomes

  1. The detection of death will be shorter

    Time frame: 1st Jan 2030

Secondary outcomes

  1. The survival rate will increase

    Time frame: 1st Jan 2030

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07622082
Lead sponsor
Lithuanian University of Health Sciences
Responsible party
Linas Darginavicius (Emergency physician, PhD, Lithuanian University of Health Sciences) — Principal investigator
First posted
Jun 2, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Jan 1, 2030 (estimated)
Last update
Jun 2, 2026

Study contacts

Linas Darginavicius, PhD
Contact
linas.darginavicius@lsmu.lt
+37065262929
Deimante Baksevice, MD
Contact
deimante.baksevice@lsmu.lt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion